Clinical benefits of FGM use, in particular a reduction in hypoglycemia, have also been reported in patients with type 2 diabetes mellitus (T2DM) on intensive insulin therapy [25,26]. The gene discussed is INS; the disease is type 2 diabetes mellitus.